Iyuda Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-064/6/26 | New | $599,999 | $599,999 | Equity Only | 06b | SEC linkSEC |
| 2025-06-066/6/25 | Amended | $1,312,337 | $359,999 | Equity Only | 06b | SEC linkSEC |
| 2024-10-2110/21/24 | New | $952,338 | $952,338 | Equity Only | 06b | SEC linkSEC |
| 2023-09-149/14/23 | New | $899,980 | $899,980 | Other | 06b | SEC linkSEC |
| 2023-09-149/14/23 | New | $1,385,262 | $1,385,262 | Equity Only | 06b | SEC linkSEC |
| 2023-09-149/14/23 | New | $342,722 | $342,722 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Ephraim Fuchs | Director |
| Robert Tennant | Executive |
Industry: Biotechnology (See others in industry)
Address:
3217 Hunting Tweed Dr.
Owings Mills, MD, 21117
Phone: 202-913-8697
Owings Mills, MD, 21117
Phone: 202-913-8697